Media Summary: Translational and Clinical Considerations of With James M. Wilson, M.D., Ph.D. Streamed live on December With Ed Weeber, Ph.D., and Jenn Daily, Ph.D. Streamed live on December

Aav Mediated Gene Therapy For Developmental And Epileptic Encephalopathies Part 1 - Detailed Analysis & Overview

Translational and Clinical Considerations of With James M. Wilson, M.D., Ph.D. Streamed live on December With Ed Weeber, Ph.D., and Jenn Daily, Ph.D. Streamed live on December In this two-day symposium, experts will discuss the latest advancements, practical applications, and ongoing challenges related to ... www.DEEPConnections.net This is a recording of Post-doc research fellow Eden Robertson from UNSW, Australia, speaks of her

Researchers are using adeno-associated viruses (AAVs) as Rodney A. Radtke, MD, considers challenges inherent in managing The National Human Genome Research Institute (NHGRI) and the National Center for Advancing Translational Sciences ...

Photo Gallery

AAV-mediated Gene Therapy for Developmental and Epileptic Encephalopathies - Part 1
Part 2: AAV-mediated Gene Therapy for Developmental and Epileptic Encephalopathies
Part 3: AAV-mediated Gene Therapy for Developmental and Epileptic Encephalopathies
LP352: A Selective 5HT2c Agonist for Developmental and Epileptic Encephalopathies
Keynote:  AAV-mediated gene therapy to the central nervous system: prospect for Angelman syndrome
AAV-mediated gene therapy approach: Ovid Therapeutics
AAV-mediated gene therapy for CTNNB1 Syndrome - Dr. Leszek Lisowski and Dr. Andrea Perez Iturralde
Assessing AAV-mediated gene therapy in preclinical models of CTNNB1 syndrome - Dr. Andrea Iturralde
AAV Avenues for Cell and Gene Therapy - E1
Rescue Meds in Severe Developmental and Epileptic Encephalopathies (DEEs) Part1: Introduction
How To Support Caregivers Of Those With A Developmental & Epileptic Encephalopathy - Eden Robertson
A gene therapy platform for treating diseases
Sponsored
Sponsored
View Detailed Profile
AAV-mediated Gene Therapy for Developmental and Epileptic Encephalopathies - Part 1

AAV-mediated Gene Therapy for Developmental and Epileptic Encephalopathies - Part 1

Introduction to

Part 2: AAV-mediated Gene Therapy for Developmental and Epileptic Encephalopathies

Part 2: AAV-mediated Gene Therapy for Developmental and Epileptic Encephalopathies

Translational and Clinical Considerations of

Sponsored
Part 3: AAV-mediated Gene Therapy for Developmental and Epileptic Encephalopathies

Part 3: AAV-mediated Gene Therapy for Developmental and Epileptic Encephalopathies

Developmental

LP352: A Selective 5HT2c Agonist for Developmental and Epileptic Encephalopathies

LP352: A Selective 5HT2c Agonist for Developmental and Epileptic Encephalopathies

LP352: A Selective 5HT2c Agonist for

Keynote:  AAV-mediated gene therapy to the central nervous system: prospect for Angelman syndrome

Keynote: AAV-mediated gene therapy to the central nervous system: prospect for Angelman syndrome

With James M. Wilson, M.D., Ph.D. Streamed live on December

Sponsored
AAV-mediated gene therapy approach: Ovid Therapeutics

AAV-mediated gene therapy approach: Ovid Therapeutics

With Ed Weeber, Ph.D., and Jenn Daily, Ph.D. Streamed live on December

AAV-mediated gene therapy for CTNNB1 Syndrome - Dr. Leszek Lisowski and Dr. Andrea Perez Iturralde

AAV-mediated gene therapy for CTNNB1 Syndrome - Dr. Leszek Lisowski and Dr. Andrea Perez Iturralde

AAV

Assessing AAV-mediated gene therapy in preclinical models of CTNNB1 syndrome - Dr. Andrea Iturralde

Assessing AAV-mediated gene therapy in preclinical models of CTNNB1 syndrome - Dr. Andrea Iturralde

Assessing

AAV Avenues for Cell and Gene Therapy - E1

AAV Avenues for Cell and Gene Therapy - E1

In this two-day symposium, experts will discuss the latest advancements, practical applications, and ongoing challenges related to ...

Rescue Meds in Severe Developmental and Epileptic Encephalopathies (DEEs) Part1: Introduction

Rescue Meds in Severe Developmental and Epileptic Encephalopathies (DEEs) Part1: Introduction

www.DEEPConnections.net This is a recording of

How To Support Caregivers Of Those With A Developmental & Epileptic Encephalopathy - Eden Robertson

How To Support Caregivers Of Those With A Developmental & Epileptic Encephalopathy - Eden Robertson

Post-doc research fellow Eden Robertson from UNSW, Australia, speaks of her

A gene therapy platform for treating diseases

A gene therapy platform for treating diseases

Researchers are using adeno-associated viruses (AAVs) as

Basics of AAV Gene Therapy

Basics of AAV Gene Therapy

Basics of

Solutions for gene therapy using a deeper analytical characterization of AAV vector development

Solutions for gene therapy using a deeper analytical characterization of AAV vector development

Gene therapy

Manufacturing Gene Medicines Workshop - Part 1

Manufacturing Gene Medicines Workshop - Part 1

MANUFACTURING

Overcoming Adherence Issues in Epileptic Encephalopathies

Overcoming Adherence Issues in Epileptic Encephalopathies

Rodney A. Radtke, MD, considers challenges inherent in managing

Seminar | Prof Stephanie Schorge - Gene Therapy in Epilepsy Treatment | GenSoc 2020-21

Seminar | Prof Stephanie Schorge - Gene Therapy in Epilepsy Treatment | GenSoc 2020-21

Uh i actually have a question uh does

Scientific Updates on Organic Acidemias and Homocystinurias - Session 5

Scientific Updates on Organic Acidemias and Homocystinurias - Session 5

The National Human Genome Research Institute (NHGRI) and the National Center for Advancing Translational Sciences ...

Roadmap to EEGs: Developmental and Epileptic Encephalopathies Part 2

Roadmap to EEGs: Developmental and Epileptic Encephalopathies Part 2

In